Cancer immunotherapy: an evolving paradigm
Crossref DOI link: https://doi.org/10.1631/jzus.B2210001
Published Online: 2022-10-17
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Aifu http://orcid.org/0000-0002-3968-3617
Text and Data Mining valid from 2022-10-01
Version of Record valid from 2022-10-01
Article History
First Online: 17 October 2022
Free to read: This content has been made available to all.